Sartorious/SRT3

€341.75

2.1%
-
1D1W1MYTD1YMAX

About Sartorious

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.

Ticker

SRT3

Sector

Healthcare

Trading on

XETRA

Industry

Scientific & Technical Instr.

CEO

Joachim Kreuzburg

Employees

14,614

Headquarters

Goettingen, Germany

Sartorious Metrics

BasicAdvanced
€22.2B
Market cap
85.77
P/E ratio
€3.01
EPS
0.44
Beta
€0.73
Dividend rate
0.28%
Dividend yield
€22.2B
0.43518
€330.00
€181.00
3.63K
€0.73
1.471
0.692
242.988
256.92
24.72%
5.26%
3.47%
10.11%
4.74%
85.772
6.537
8.538
113.43
0.28%
0.28%
0.28%
-18.66%
-69.63%
13.29%
-0.8%
1.41%

What the Analysts think about Sartorious

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 3 analysts.
6.8% upside
High €415.00
Low €325.00
€341.75
Current price
€365.00
Average price target

Sartorious Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.97% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
€849.8M
4.82%
Net income
€8.3M
-4.6%
Profit margin
0.97%
-9.35%

Sartorious Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 29.63%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
€2.24
€1.69
€1.26
€1.04
€0.95
Expected
€1.69
€2.19
€1.90
€1.29
€1.35
Surprise
32.54%
-22.65%
-33.68%
-19.38%
-29.63%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Deutsche Börse. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Sartorious stock?

Sartorious (SRT3) has a market cap of €22.2B as of April 15, 2024.

What is the P/E ratio for Sartorious stock?

The price to earnings (P/E) ratio for Sartorious (SRT3) stock is 85.77 as of April 15, 2024.

Does Sartorious stock pay dividends?

Yes, the Sartorious (SRT3) stock pays dividends to shareholders. As of April 15, 2024, the dividend rate is €0.73 and the yield is 0.28%. Sartorious has a payout ratio of 24.72% on a trailing twelve-month basis.

When is the next Sartorious dividend payment date?

The next Sartorious (SRT3) dividend payment date is unconfirmed.

What is the beta indicator for Sartorious?

Sartorious (SRT3) has a beta rating of 0.44. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Sartorious stock price target?

The target price for Sartorious (SRT3) stock is €365, which is 6.8% above the current price of €341.75. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Sartorious stock

Buy or sell Sartorious stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing